If you have atrial fibrillation (AFib), left atrial appendage closure may reduce your risk of stroke. This procedure safely seals off a small part of your heart to help prevent blood clots. Left atrial appendage closure is an alternative to blood thinners for eligible patients.
At Stanford Health Care, we work together to find the best way to reduce your risk of stroke. We offer left atrial appendage closure using the Watchman FLX™ and the Amplatzer™ Amulet™. These devices are FDA-approved to lower the risk of AFib-related strokes.
Stanford Health Care is one of the few centers in the country that performs left atrial appendage closure without general anesthesia and transesophageal echocardiogram. Our approach is less invasive, and you go home the same day.
WHAT WE OFFER YOU FOR LEFT ATRIAL APPENDAGE CLOSURE
- Extensive experience and promising results with the Watchman FLX and Amplatzer Amulet devices, offering both devices commercially before any other program in Northern California after FDA approval.
- Team approach to reducing AFib-related stroke risk, bringing together top electrophysiologists, interventional cardiologists, surgeons, and imaging specialists.
- Tailored care for your needs, with our team taking the time to explain your options and the potential benefits and risks of each option.
- Active clinical research program to develop future left atrial appendage closure techniques and devices.